Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

TD Cowen Maintains Market Perform on Amedisys, Raises Price Target to $101

Author: Benzinga Newsdesk | July 31, 2023 03:43pm
TD Cowen analyst Gary Taylor maintains Amedisys (NASDAQ:AMED) with a Market Perform and raises the price target from $84 to $101.

Posted In: AMED

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist